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Several tuberculins, strengths and setting methods are in everyday use. We wanted to compare the
Norwegian reference adrenaline–Pirquet test with the internationally recommended Mantoux PPD test and
Rhoditest.
In responders of a random sample of young adults, with randomization of test subjects, we intra-individually
compared the adrenaline-Pirquet (aP) test with Norwegian-produced synthetic medium tuberculin (SMT) with
either the Mantoux test with PPD 2 tuberculin units (TU) (M2), the Mantoux–PPD 5 TU (M5) or the PPD 2
TU–Rhoditest (Rh). The criteria for a positive reaction were  4mm for the aP test, 10mm for the M2 test,
6mm for the M5 test and 2mm for the Rh test. Strongly positive reactions were defined as aP test 10mm and
M2/M5 test 15mm.
One of the tuberculin tests was positive while the comparison test was negative in 14% of the M2 test group
(n = 236), 15% in the M5 test group (n = 162) and 20% in the Rh test group (n = 187). The three PPD
tests had positive reactions 3–10 times as often, with a simultaneous negative aP test, than vice versa.
Strongly positive reactions occurred in 7% of the aP tests (10mm), 32% of the M2 tests (15mm) and in
41% of the M5 tests (15mm). Receiver operating characteristic (ROC) curves gave the best agreement, with
aP test 3mm compared with the M2 and the Rh tests. Regression equations are presented for transforma-
tions of the Norwegian reference method of adrenaline–Pirquet results to internationally recommended PPD
tests.
The international recommendations, globalization in general and the skill of Norwegian public health nurses in
performing intra-dermal BCG suggest a future shift to the PPD 2 TU Mantoux test in Norway. Due to the lack of
sensitivity and specificity of all tuberculin tests they might be used in targeted tuberculin testing and not as a general
screening procedure in a low-incidence tuberculosis area with BCG-vaccinated inhabitants.
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The use of the Mantoux PPD tuberculin test is recom-
mended by WHO (1) and IUATLD (2) when assessing the
presence of infection with Mycobacterium tuberculosis.
However, other tuberculins and/or setting techniques are
routinely used in other countries; such as the Heaf and Tine
tests using old tuberculin (OT) in Great Britain (3) and the
PPD Rhoditest in France (4). Since the 1930s a modifica-
tion of von Pirquet’s skin scarification method (5), addingReceived 9 October 2000 and accepted in revised from 5 December
2000
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0954-6111/01/030205+07 $35?00/0adrenaline (6) to synthetic medium tuberculin (7), has been
used for most tuberculin testing in Norway.
We initiated this tuberculin study in order to compare
different tuberculin tests. When comparing historic and
present Norwegian tuberculin data with those from other
countries we need to evaluate the agreement and the
relationship between this adrenaline–Pirquet test with
synthetic medium tuberculin and the internationally-
recommended PPD Mantoux test. As we have recognized
a loss in experience in tuberculin setting and reading among
Norwegian health workers in the last decade, we included a
PPD multi-puncture test (Rhoditest) (4) as an alternative
and simple screening method. Finally, we wanted to
evaluate the consequences of using different tuberculin
screening methods for the fraction of strongly positive
reactions, thereby indicating a need for a follow-up
examination.# 2001 HARCOURT PUBLISHERS LTD
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STUDY POPULATION
A random sample of 1200 men and women 20–44 years
of age were invited to participate in the Norwegian part
of the European Community Respiratory Health Survey
(8), of which 903 subjects (75%) attended the study
from September 1992 to June 1993. Of the 891 persons
who underwent tuberculin testing, 590 (66%) returned after
2–7 days (42–171 h) to have their tuberculin reactions
read. In a previous paper we have documented that
the elapsed time, within this time-span, from setting
to reading the adrenaline–Pirquet reaction was of no
importance (9).
Five subjects were only adrenaline–Pirquet tested and
were omitted from the statistical analyses. Of the remaining
585 participants, nine subjects (1?5%) were previously
tuberculin converters, 18 subjects had missing data on BCG
vaccination, and 558 subjects (95%) were confirmed BCG-
vaccinated at about 14 years of age (10).
TUBERCULIN TESTING
All participants were tested with adrenaline–Pirquet (aP)
skin-scratch in duplicate on the volar side of the left
forearm. The choice of the second tuberculin test was
randomized to different days of the week. Mantoux PPD
intra-dermal injection of 2 tuberculin units (TU) (M2) or 5
TU (M5) was set on the dorsal side of the forearm, or a
multi-puncture PPD 2TU test (Rhoditest) (Rh) was placed
5 cm below the distal aP scratch. Thus, three study groups
were formed, with the aP test as the common denominator
(Table 1). The varying daily attendance rate and some delay
in tuberculin delivery made the numbers unequal in the
three tuberculin groups. An experienced public health nurse
performed all tuberculin testing and non-blinded reading.
The aP test is a modification of von Pirquet’s skin
scarification method (5) with Norwegian-produced syn-
thetic medium tuberculin (SMT) (7) and adrenaline (6,11).
The duplicate aP test should be read within 48–72 h as the
greatest value perpendicular to the scratch. The larger of
the duplicate aP reactions is used. The criterion of a
positive aP tuberculin reaction is conventionally 4mm
(12). In the Mantoux tests (1,2) 0?1ml of PPD tuberculin
solution is injected intra-dermally. The reaction should be
read at 72 h. The recommended criterion of a positive
Mantoux reaction is an infiltrate of 6mm with 2 TU PPD
tuberculin and 10mm with 5 TU PPD tuberculin, read as
the greatest diameter of the infiltration (1,13). A strongly
positive reaction needing a follow-up examination has the
cut-off points of aP 10mm, M2 and M5 15mm (12,14).
We used the tuberculin PPD RT23 produced by Statens
Serum Institutt (Copenhagen, Denmark), delivered in 2 TU
and 5 TU concentrations.
The multi-puncture skin test (Rhoditest1; Institute
Pasteur-Me`rieux, Lyon, France) (4) is performed with a
disposable hard-plastic device with nine sharp needles
sealed in a French-produced PPD tuberculin solution(30?000 IUml71) with a 2 IU (TU) test dose. The unsealed
applicator is pressed onto the skin on the volar side of the
forearm for 5 sec. The appearance of a pressure-circle on
the skin ensures the correct penetration depth of the needles
into the skin. The test should be read at 72 h, with 2mm
as a positive reaction.
STATISTICAL METHODS
We assessed the agreement between the PPD tests and the
aP test by the kappa coecient (15). The linear weighted
kappa (16) was used to reduce its dependency on the
number of categories (17). Symmetry in the 363 tables was
tested by the generalization of McNemar’s test for 262
tables (18). Linear regression analyses were made for the
relationship between aP reactivity and each of the three
PPD tests (18).
We investigated the effect of changing the criterion for a
positive aP test by calculating sensitivity and specificity for
every read value and drawing receiver operating character-
istic (ROC) curves (15) for each PPD test group.
Results
The subjects were randomized to one of three PPD test
groups. Table 1 shows the means and the standard
deviations (SD) of the aP test and the three PPD tests.
The distribution of gender (51% men), age (mean 34 years)
and aP test reactivity (mean 4?8mm) did not differ between
the three test groups.
Table 2 presents the complete dataset with the intra-
individual relationship between the aP test reactivity and
the corresponding PPD test. The tuberculin reactions were
approximately twice as large in the Mantoux tests
compared with the aP test (in mm). The Rh test had the
smallest reactions but the highest positive rate (78%).
There were more non-reactors (0mm) and positive
reactors in the M2 test and in the Rh test compared with
the aP test. In the M5 test the number of non-reactors was
equal to the aP test, but had more positive reactors than the
aP test (Table 3).
Table 3 presents the absolute agreement between the aP
test and the corresponding PPD test in each test group with
respect to non-reaction (0mm), negative reaction except
zero and positive tuberculin reaction (363 tables). An
absolute agreement existed in a total of 184 subjects (78%),
129 subjects (79%) and 137 subjects (73%) in the M2 test
group, M5 test group and the Rh test group, respectively.
When including the non-reactors (0mm) in the negative
tuberculin test groups (262 tables), we observed that one
test was positive and the other test was negative in 34
persons (14%) in the M2 test group, 25 persons (15%) in
the M5 test group and 37 persons (20%) in the Rh test
group. There was three- to 10-fold more positive reactors
(31/3, 19/6, 32/5) in the different PPD tests but negative in
the aP test than vice versa.
A linear trend was observed between the size of the
aP and the PPD infiltrates (Table 2). The following
linear regression equations with residual standard
TABLE 1. Tuberculin reactivity and sex and age distribution in randomized groups of young Norwegian adults tested with the
Norwegian reference method of adrenaline–Pirquet (a–Pirquet) with synthetic medium tuberculin (SMT), as well as with the
Mantoux or Rhoditest with PPD tuberculin
Group M2 (n=236) Group M5 (n=162) Group Rh (n=187)
a–Pirquet SMT Mantoux–PPD
2TU
a–Pirquet SMT Mantoux–PPD
5 TU
a–Pirquet SMT Rhoditest–PPD
2 TU
Tuberculin reactivity (mm)
Mean 4?8 10?1 4?9 12?8 4?7 3?6
SD 3?1 6?5 3?1 6?9 2?8 2?5
Gender (%)
Men 51?7 53?0 47?6
Age (years)
Mean 34?0 33?5 34?3
SD 6?9 6?7 7?0
TABLE 2. Comparing adrenaline–Pirquet synthetic medium tuberculin reactivity with Mantoux–PPD 2 TU, Mantoux–PPD 5
TU or PPD 2 TU-Rhoditest in young Norwegian adults
Adrenaline–Pirquet synthetic medium tuberculin reactivity (mm)
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 no
Mantoux– 0 21 12 3 – – – – 1 – – – – – – – 37
PPD 2 1 1 1 2 – – – – – – – – – – – – 4
TU (mm) 2 1 – 1 – – – – – – – – – – – – 2
3 – 1 5 – – – – – – – – – – – – 6
4 – 1 3 – – – – – – – – – – – – 4
5 1 1 1 2 2 – – – – – – – – – – 7
6 – – 4 3 – – – – – – – – – – – 7
7 – – 3 3 3 1 1 1 – – – – – – – 12
8 – 1 2 2 – 1 1 1 – – – – – – – 8
9 – – – 2 – 1 – – 1 1 – – – – – 5
10 – – 1 6 4 11 7 4 3 1 – – – – – 37
11 – – – – – – – – – 1 – – – – – 1
12 – – 1 3 2 3 2 5 5 – 1 – – – – 22
13 – – – – 1 1 3 – 1 – 1 – – – – 7
14 – – – – 1 1 – – – – – – – – – 2
15 – – – – 5 4 6 4 9 5 1 – – – – 34
16 – – – – – 1 – – 1 – 1 – – – – 3
17 – – – – – – 2 1 1 – 3 – – – – 7
18 – – – – – 1 1 2 6 – 1 – – – – 11
19 – – – – – – – – – – – – – – – 0
20 – – – – – – – 3 2 2 2 – – – 10
21 – – – – – – – – 1 – – – – – – 1
22 – – – – – – – 2 – 1 2 – – – – 5
23 – – – – – 1 – – – – – – – – – 1
24 – – – – – – – – – – – – – – – 0
25 – – – – – – 1 – – – – – 1 – 1 3
no 24 17 26 21 18 26 24 24 30 11 12 0 2 0 1 236
Mantoux– 0 10 5 – – – – – – – – – – – – – 15
PPD 5 1 1 – – – – – – – – – – – – – – 1
TU (mm) 2 – 1 – – – – – – – – – – – – – 1
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3 1 2 – – – – – 1 – – – – – – – 4
4 1 – 1 – 1 – – – – – – – – 1 – 4
5 – 2 – 1 – – – – – – – – – – – 3
6 – – 3 2 – – – – – – – – – – – 5
7 – – – – – 1 – – – – – – – – – 1
8 – 1 1 2 1 – 1 – – – – – – – – 6
9 1 – – 1 – – – – – – – – – – – 2
10 1 – – 6 4 2 1 – – – – – – – – 14
11 – – – 1 – – – – – – – – – – – 1
12 – 3 2 3 3 7 7 – – – 1 – – – – 26
13 – – – – 2 – 1 – – – – – – – – 3
14 – – – 1 1 1 3 – – – – – – – – 6
15 – – – 1 1 4 5 1 4 – 3 – – – – 19
16 – – – – – – 1 – 1 – – – 1 – – 3
17 – – – – – – – 1 – – – – – – – 1
18 – – – – 1 4 2 2 2 – 2 – – – – 13
19 – – – – – – – – – – – – – – – 0
20 – – – – – 1 4 4 3 – 3 – – – – 15
21 – – – – – – – – – – – – – – – 0
22 – – – – – 1 2 2 – 1 2 – – – – 8
23 – – – 1 – 1 – – – – – – – – – 2
24 – – – – – – – – – 1 – – – – – 1
25 – – – – – 1 1 – 3 – – 1 1 – – 7
26 – – – – – – – – – – – – – – – 0
27 – – – – – – – – – – – – – – – 0
28 – – – – – – – – – – – – – 1 – 1
no 15 14 7 19 14 23 28 11 13 2 11 1 2 2 – 162
Rhoditest– 0 15 7 2 2 – 1 – – 1 – 1 – – – – 29
PPD 2 1 2 2 6 – – – 1 1 – – – – – – – 12
TU (mm) 2 – 1 10 4 4 – – – – – – – – – – 19
3 – – 1 6 12 4 4 – – – – – – – – 27
4 – – – 7 5 6 13 5 3 – 2 – – – – 41
5 – – 1 1 3 5 7 4 4 1 2 – – – – 28
6 – – – – 1 1 – 1 6 2 2 – – – – 13
7 – – – 1 – – 1 – 3 2 1 – – – – 8
8 – – – – 1 – – – – – 2 – – – 3
9 – – – – – – – 1 – – – – – – – 1
10 – – – – – 1 – – 1 2 1 – – – – 5
11 – – – – – – – – – – – – – – – 0
12 – – – – – – – – – – – – – – – 0
13 – – – – – – – – – – – – – – 0
14 – – – – – – 1 – – – – – – – – 1
no 17 10 20 21 26 18 27 12 18 7 11 0 0 0 0 187
TABLE 2. Continued
Adrenaline–Pirquet synthetic medium tuberculin reactivity (mm)
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 no
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parenthesis):
. Mantoux–PPD 2 TU=1?64 (0?44)þ1?74 (0?08)
adrenaline–Pirquet (RSD=3?72);
. Mantoux–PPD 5 TU=4?57 (0?70)þ1?67 (0?12)
adrenaline–Pirquet (RSD=5?25);. Rhoditest PPD 2 TU=0?73 (0?25)þ0?63 (0?05)
adrenaline–Pirquet (RSD=1?77).
In Fig. 1 we present ROC curves for the three PPD tests
by varying the cut-off point for a positive aP test. The
conventional positive cut-off points in the three PPD tests
were used as the ‘true’ value. Every read value of the aP test
TABLE 3. Comparing intra-individual agreement with different tuberculin methods in young Norwegian adults
Adrenaline–Pirquet
(positive 4mm)
Mantoux–PPD 5 TU
(positive: 6mm)
(n=236)
Mantoux–PPD 5 TU
(positive: 10mm
(n=162)
Rhoditest PPD 2 TU
(positive: 2mm
(n=187)
0 mm 1–5 mm 6 mm 0 mm 1–9 mm 10 mm 0 mm 1 mm 2 mm
0 mm 21 3 0 10 4 1 15 2 0
1–3 mm 15 18 31 5 17 18 11 8 32
4 mm 1 2 145 0 6 101 3 2 114
Total 37 23 176 15 27 120 29 12 146
Linear-weighted kappa: (SE) 0?66 (0?04) 0?63 (0?06) 0?56 (0?06)
95% CI (0?58–0.74) (0?52–0?75) (0?45–0?67)
McNemar’s test of symmetry
P-value 50?01 0.07 50?01
FIG 1. Receiver operated characteristic (ROC) curves on
sensitivity and specificity between the PPD-tests and the
adrenaline–Pirquet SMT tuberculin test. Rhoditest PPD 2
TU (—); Mantoux–PPD 5 TU (– – –); Mantoux–PPD 2
TU (? ? ? ?).
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basis for calculating sensitivity and specificity. The best cut-
off point is defined as that which maximizes the sum of the
sensitivity and specificity. We found best agreement with
the M2 and the Rh test results with a criterion of 3mm
for a positive cut-off point in the aP test, while the
corresponding criterion for the M5 test was 4mm.
With the recommended cut-off points for a strongly
positive reaction (aP 10mm, M2 and M5 15mm) 7% of588 aP-tested subjects, 32% of 236 M2-tested subjects and
41% of 162 M5-tested subjects would need a follow-up. Of
the 401 subjects tested with both the aP test and the
Mantoux tests, 15 subjects with strongly positive aP
reactions were not recognized as such by the Mantoux test.
Out of 145 subjects with strongly positive reactions from
the Mantoux test, 121 were not recognized by the aP test.
From the regression lines presented we found a correspond-
ing cut-off point for a strongly positive adrenaline–Pirquet
reaction 10mm to be 20mm for both the Mantoux–PPD
2 TU and 5 TU and 6mm for the Rhoditest.
Discussion
When using the recommended criteria for positive tuber-
culin tests we observed that the adrenaline–Pirquet test gave
8–15% less positive reactors than both the Mantoux tests
and the Rhoditest. Furthermore, there was a variation from
7% to 41% in strongly positive reactors between the tests. In
addition, the disagreement in non-reactors (0mm) between
the tests varied between 12 and 48%, indicating that the
tuberculin reaction is not only dependent upon immunolo-
gical mycobacterial reactivity, but also on the test applied.
Tuberculins are produced in many laboratories using
different methods and strains of M. tuberculosis. They may
have different properties even though they are standardized
against the old tuberculin (S-OT) or the PPD tuberculin
standards (PPD-S) (4,6,7,11). No tuberculin is specific forM.
tuberculosis as it also reacts to non-tuberculous mycobacter-
ia. By skin-testing with tuberculin and sensitins made from
non-tuberculous mycobacteria, Bjerkedal (19) in Norway in
1961–1962 and Larsson et al. (20) in Sweden in 1986–1990,
demonstrated that most of the PPD tuberculin reactivity in
children was due to non-tuberculous mycobacteria.
The mycobacteria possess numerous antigenic structures,
which may explain differences in properties when used in
vaccination results and tuberculin testing. Closs et al. (21),
who studied the Copenhagen strain of BCG by crossed
immuno-electrophoresis, found the cell wall-associated
210 H. F. JENTOFT ET AL.antigen BCG 60 to be a major constituent of the PPD
tuberculin. The MPB 64 protein secreted from young
cultures of M. tuberculosis also has strong antigenic
properties, as demonstrated by Harboe et al. (22).
Nakamura et al. (23) recently documented MPB 64 to be
highly sensitive and specific with patch testing in subjects
with active tuberculosis, but gave no reaction in the PPD-
positive healthy controls. However, Wilcke et al. (24) found
no advantage in using the MPB 64 ‘tuberculin’ compared
with PPD RT 23.
We have previously demonstrated that the reproduci-
bility of the adrenaline–Pirquet test was comparable with
the Mantoux–PPD test (9). The intra-dermal injection
technique in the Mantoux test ensures that a given amount
of tuberculin reaches the reacting tissues. The superficial
application of the adrenaline–Pirquet as well as the
Rhoditest may fail to introduce the tuberculin into the
skin. This might increase the risk of false-negative reactions
despite dual or multiple skin perforations. However, in the
present study the number of non-reactors (0mm) was
higher in the Mantoux PPD 2 TU than in the adrenaline–
Pirquet test and on the same level when comparing the
adrenaline–Pirquet test with the Mantoux–PPD 5 TU test.
The Rhoditest demonstrated the greatest number of non-
reactors and is probably the least suited as a screening test.
The different qualities, strengths and application meth-
ods of the tuberculins are reflected in different criteria for a
positive reaction. When comparing the skin perforation
methods, the PPD 2 TU Rhoditest and the synthetic
medium tuberculin adrenaline–Pirquet test, we are prob-
ably looking into differences in properties and strengths
between two different tuberculins. For example, the
Rhoditest presented nearly twice as many non-reactors
(29/15) as the adrenaline–Pirquet test in the same subjects.
It may be dicult to read the Rhoditest reactions (4) since it
has ill-defined borders and small reactions. Adding adrena-
line to the Norwegian-produced synthetic medium tuber-
culin is said to triple the adrenaline–Pirquet reaction,
making it easier to read (11). In this survey, all tuberculin
test setting and reading was done by the same well-trained
public health nurse. The reading of the Mantoux test seems
to favour certain millimeters used for action in daily
practice to some degree (Table 2). Therefore, in addition to
this non- blinded reading, a blinded reading of the reactions
drawn by the first observer was performed. When using this
blinded, and more evenly distributed reading result, the
relationships between the tuberculin tests remained.
The Mantoux–PPD 2 TU and the Mantoux–PPD 5 TU
demonstrated maximum infiltrates of 25 mm and 28 mm in
diameter, respectively. However, despite these large PPD
infiltrates no participant reported long-lasting ulcers. The
skin perforating methods of adrenaline–Pirquet and PPD 2
TU Rhoditest had a maximum reaction of 14mm.
The disagreement in sensitivity between the tests should
be considered when comparing the adrenaline–Pirquet
tuberculin reactivity in Norwegians with that of other
populations using other tuberculin tests. The specificity of
the tuberculin tests with regard to disease has not been
evaluated in this study. With the recommended follow-up
cut-off point (15mm), 41% of those tested with theMantoux–PPD 5 TU would need a further examination. To
follow up such a large number of subjects would be
considered laborious and of limited value since all subjects
had normal chest X-rays and had not have developed
tuberculosis by the year 2000.
To conform with international recommendations as well
as globalization in general are the strongest arguments for
introducing the Mantoux–PPD 2 TU tuberculin test for
routine use in Norway. In view of our findings we conclude
that routine tuberculin testing in a low-incidence tubercu-
losis area with a very high BCG coverage rate is of limited
use. In this respect there are probably no differences
between the different tuberculins and setting methods,
despite some differences in the levels of non-reactors. The
validity of contact tracing of subjects with an infiltrate of
15mm with the Mantoux–PPD 2 TU test is questioned.
The most cost-effective cut-off point of the Mantoux–PPD
2 TU test for contact tracing, of subjects previously BCG-
vaccinated, should be examined in future studies.
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